发明名称 THERAPEUTIC AGENTS 414
摘要 A compound of Formula (I) is useful in the treatment or prevention of a disease or medical condition mediated through glucokinase (GLK or GK), leading to a decreased glucose threshold for insulin secretion.
申请公布号 WO2010015849(A2) 申请公布日期 2010.02.11
申请号 WO2009GB50970 申请日期 2009.08.03
申请人 ASTRAZENECA AB;ASTRAZENECA UK LIMITED;BENNETT, STUART, NORMAN, LILE;BONN, PETER, GUSTAF;BRINK, MIKAEL, DAN;BUTLIN, ROGER, JOHN;CAMPBELL, LEONIE;DAVIES, ROBERT, DARREN, MORSE;FAEGERHAG, JONAS, RICKARD;JURVA, ULRIK;POINTON, HELEN, CLAIRE;ROBB, GRAEME, RICHARD;SCHNECKE, VOLKER;SVENSSON HENRIKSSON, ANETTE MARIE;WALKER, ROLF, PETER;WARING, MICHAEL, JAMES;WESTERLUND, CHRISTER, RALF 发明人 BENNETT, STUART, NORMAN, LILE;BONN, PETER, GUSTAF;BRINK, MIKAEL, DAN;BUTLIN, ROGER, JOHN;CAMPBELL, LEONIE;DAVIES, ROBERT, DARREN, MORSE;FAEGERHAG, JONAS, RICKARD;JURVA, ULRIK;POINTON, HELEN, CLAIRE;ROBB, GRAEME, RICHARD;SCHNECKE, VOLKER;SVENSSON HENRIKSSON, ANETTE MARIE;WALKER, ROLF, PETER;WARING, MICHAEL, JAMES;WESTERLUND, CHRISTER, RALF
分类号 主分类号
代理机构 代理人
主权项
地址